CASI Pharma (NASDAQ: CASI) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

As of March 31, 2016, CASI had cash and cash equivalents of $13.9 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.